Hsbc Holdings PLC Trims Position in Humana Inc. $HUM

Hsbc Holdings PLC cut its stake in shares of Humana Inc. (NYSE:HUM) by 2.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 318,091 shares of the insurance provider’s stock after selling 8,933 shares during the period. Hsbc Holdings PLC’s holdings in Humana were worth $126,221,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Johnson Financial Group Inc. purchased a new position in Humana during the second quarter valued at approximately $26,000. Trust Co. of Vermont bought a new position in Humana in the 2nd quarter valued at $28,000. Bogart Wealth LLC boosted its holdings in Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after purchasing an additional 48 shares during the period. MidFirst Bank purchased a new position in shares of Humana during the 2nd quarter valued at $35,000. Finally, Montag A & Associates Inc. grew its position in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on HUM shares. Royal Bank Of Canada increased their price objective on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Robert W. Baird set a $390.00 price target on Humana in a report on Thursday, July 30th. Wolfe Research reiterated an “outperform” rating and set a $450.00 price target on shares of Humana in a research report on Monday. Finally, Seaport Research Partners lowered Humana to a “neutral” rating in a report on Wednesday, May 20th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $403.91.

Humana Trading Up 0.6%

NYSE HUM opened at $388.92 on Wednesday. The stock’s 50-day simple moving average is $383.88 and its two-hundred day simple moving average is $285.00. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $46.70 billion, a price-to-earnings ratio of 36.79, a PEG ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same period in the prior year, the business earned $6.27 EPS. Research analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.